During the past 20 years, artemisinin-based medicines have contributed to a decrease in malaria-related mortality. Looking ahead to the next 20, resistance to these medicines will be one of the toughest challenges we will face. Today, we are seeing the first signs of such resistance in Africa. Take a look at this image slideshow to learn about how MMV is approaching this issue today and preparing for the future.